Purpose Multiple-gene sequencing is entering practice, but its clinical value is unknown.
We evaluated the performance of a customized germline-DNA sequencing panel for cancer-risk …

To chart cell composition and cell state changes that occur during the transformation of
healthy colon to precancerous adenomas to colorectal cancer (CRC), we generated single-cell …

Importance The practice of genetic testing for hereditary breast and/or ovarian cancer (HBOC)
is rapidly evolving owing to the recent introduction of multigene panels. While these tests …

Gene panels for hereditary breast and ovarian cancer risk assessment are gaining
acceptance, even though the clinical utility of these panels is not yet fully defined. Technical …

Purpose We examined racial/ethnic differences in the usage and results of germ-line
multiple-gene sequencing (MGS) panels to evaluate hereditary cancer risk. Methods We collected …

Purpose Women with BRCA1 or BRCA2 (BRCA1/2) mutations must choose between
prophylactic surgeries and screening to manage their high risks of breast and ovarian cancer, …

Purpose Multiplex gene panel testing (MGPT) allows for the simultaneous analysis of
germline cancer susceptibility genes. This study describes the diagnostic yield and patient …

Background Women with mutations in the BRCA1 or BRCA2 cancer susceptibility genes face
unique choices regarding management of their high risk for breast and ovarian cancer that …

Objectives— To determine the serum and synovial fluid concentrations of ceftiofur sodium
after intraarticular (IA) and intravenous (IV) administration and to evaluate the morphologic …

Background Little is known about the psychological outcomes of germline multigene panel
testing, particularly among diverse patients and those with moderate‐risk pathogenic variants …